Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment. - Xue H; Kemp TJ; Li C; Roche NV; Bakouny Z; Labaki C; Lee GM; Trowbridge R; Strauss S; Hughes ME; Lin NU; Choueiri TK; et al. (Human vaccines & immunotherapeutics, 2025)